VAS
RDY icon

Vestmark Advisory Solutions’s Dr. Reddy's Laboratories RDY Stock Holding History

Vestmark Advisory Solutions’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,952
Closed -$318K – 1523
2026
Q1 		$318K Buy
+22,952
New +$320K ﹤0.01% 1165
2025
Q2 		– Sell
-36,180
Closed -$477K – 807
2025
Q1 		$477K Buy
36,180
+20,258
+127% +$280K 0.01% 520
2024
Q4 		$251K Sell
15,922
-4,813
-23% -$72.3K 0.01% 526
2024
Q3 		$329K Buy
+20,735
New +$334K 0.01% 433
2021
Q1 		– Sell
-24,200
Closed -$345K – 742
2020
Q4 		$345K Buy
24,200
+600
+3% +$8.08K 0.04% 440
2020
Q3 		$328K Buy
23,600
+1,040
+5% +$12.4K 0.04% 403
2020
Q2 		$239K Buy
+22,560
New +$229K 0.04% 472

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vestmark Advisory Solutions's RDY Position: Q2 2026 in Review

Vestmark Advisory Solutions sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 22,952 shares — an estimated $318K sold.

Vestmark Advisory Solutions first reported a position in RDY in Q2 2020 and held it in 7 quarters. The position peaked at $477K in Q1 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Vestmark Advisory Solutions reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 22,952 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $318K.
  • Vestmark Advisory Solutions first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 7 quarters.
  • Vestmark Advisory Solutions's Dr. Reddy's Laboratories position peaked at $477K in Q1 2025.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.